Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05256160 · ClinicalTrials.gov registry record · NA
Cortical Excitability in Cyclic Vomiting Syndrome
A NA study of Cyclic Vomiting Syndrome, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 110
- Enrollment target
- 1
- Study location
NCT05256160 is a NA study of Cyclic Vomiting Syndrome that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 110 participants, above the 96-participant average among 3 other Cyclic Vomiting Syndrome trials with a reported enrollment target (15% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05256160, a NA study of Cyclic Vomiting Syndrome, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
- 1
- Study location
Study Summary
This exploratory study will determine if there are differences in cortical excitability between patients suffering from cyclic vomiting syndrome (CVS) and healthy control subjects, as assessed by a non-invasive method of brain stimulation (Transcranial Magnetic Stimulation, TMS).
Conditions Studied
Interventions
- OTHER TMS Paired-Pulse assessment of cortical excitability
- OTHER Autonomic activity
Study Locations (1)
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2022-05-16 |
| Est. Completion | 2027-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05256160
The ClinicalTrials.gov registry entry for NCT05256160 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 96-participant average among 3 other Cyclic Vomiting Syndrome trials with a reported enrollment target (15% higher). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cyclic Vomiting Syndrome appearing as the primary indexed condition, and to 2 interventions - of which TMS Paired-Pulse assessment of cortical excitability is the first listed.
NCT05256160 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05256160 about?
NCT05256160 is a clinical study titled "Cortical Excitability in Cyclic Vomiting Syndrome". This exploratory study will determine if there are differences in cortical excitability between patients suffering from cyclic vomiting syndrome (CVS) and healthy control subjects, as assessed by a non-invasive method of brain stimulation (Transcranial Magnetic Stimulation, TMS).
What is the current status of trial NCT05256160?
This trial is currently recruiting. It is a NA study. The enrollment target is 110 participants. The study started on 2022-05-16. Estimated completion is 2027-06.
What conditions does trial NCT05256160 study?
This clinical trial studies the following conditions: Cyclic Vomiting Syndrome.
What interventions are being tested in trial NCT05256160?
The interventions under investigation include: TMS Paired-Pulse assessment of cortical excitability (OTHER), Autonomic activity (OTHER).
Who is sponsoring clinical trial NCT05256160?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05256160 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cyclic Vomiting Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.